From the clinic to home: FDA approves at-home Leqembi® injections
Reviewed by Joel Salinas, MD The U.S. Food and Drug Administration (FDA) has approved a new way to take Leqembi® (lecanemab), a treatment for people in the early stages of Alzheimer’s disease. Until now, Leqembi has only been available through an intravenous (IV) infusion given at a clinic every two weeks. With the FDA’s latest …
From the clinic to home: FDA approves at-home Leqembi® injections Read More »